Markets

Johnson & Johnson’s Price Target Cut at UBS (JNJ)

Healthcare products maker Johnson & Johnson ( JNJ ) on Wednesday saw its price target lowered by analysts at UBS.

The firm said it cut its target for JNJ to $74, which suggests a nearly 13% upside to the stock's Tuesday closing price of $65.77. UBS said it made the move due to lower recent market multiples in the healthcare space, but maintained its "Buy" rating.

Johnson & Johnson shares posted modest gains in premarket trading Wednesday.

The Bottom Line

Shares of Johnson & Johnson ( JNJ ) have a 3.47% dividend yield, based on last night's closing stock price of $65.77. The stock has technical support in the $60-$62 price area. If the shares can firm up, we see overhead resistance around the $66-$68 price levels.

Johnson & Johnson ( JNJ ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

JNJ

Other Topics

Stocks

Latest Markets Videos